drugset / Trial / NCT04499755

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

NCT04499755 ↗

Phase 3 Recruiting 100 enrolled Tanta University
RandomizedParallel-groupTriple-blindTreatment

Summary

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Timeline

Start
2020-06-01
Primary completion
2030-12-01
Completion
2030-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nucleo CMP Forte Unknown — —

Indications